These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening. Greenberg F, Del Junco D, Weyland B, Faucett WA, Schmidt D, Rose E, Alpert E. Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1391-3. PubMed ID: 1720281 [Abstract] [Full Text] [Related]
23. Second trimester screening for Down's syndrome: 7 years experience. Beaman JM, Goldie DJ. J Med Screen; 2001 Nov; 8(3):128-31. PubMed ID: 11678551 [Abstract] [Full Text] [Related]
24. Correlations between first and second trimester markers for Down's syndrome screening. Campogrande M, Viora E, Errante G, Bastonero S, Sciarrone A, Grassi Pirrone P, Perona M, Mancini G, Dall'Amico D, Pavanello E, Guaraldo V. J Med Screen; 2001 Nov; 8(3):163-4. PubMed ID: 11678558 [No Abstract] [Full Text] [Related]
25. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin. Spencer K, Carpenter P. BMJ; 1993 Sep 25; 307(6907):764-9. PubMed ID: 7693095 [Abstract] [Full Text] [Related]
27. Maternal serum screening for Down's syndrome in the first trimester of pregnancy. Biagiotti R, Cariati E, Brizzi L, D'Agata A. Br J Obstet Gynaecol; 1995 Aug 25; 102(8):660-2. PubMed ID: 7544611 [No Abstract] [Full Text] [Related]
28. Strategies for antenatal detection of Down's syndrome. Wyllie JP, Madar RJ, Wright M, Burn J, Wren C. Arch Dis Child Fetal Neonatal Ed; 1997 Jan 25; 76(1):F26-30. PubMed ID: 9059182 [Abstract] [Full Text] [Related]
30. Lens culinaris agglutinin-reactive alpha-fetoprotein, an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome. Yamamoto R, Azuma M, Hoshi N, Kishida T, Satomura S, Fujimoto S. Hum Reprod; 2001 Nov 25; 16(11):2438-44. PubMed ID: 11679535 [Abstract] [Full Text] [Related]
31. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study]. Bian XM, Liu JT, Qi QW, Jiang YL, Li Y, Liu SY, Hao N, Zhou J, Lü SM, Zhu BS, Wang H, Xu ZF, Pan XY, Liao C, Cai Y, Wang H, Wang Z, Zhu J, Hu YL. Zhonghua Fu Chan Ke Za Zhi; 2008 Nov 25; 43(11):805-9. PubMed ID: 19087560 [Abstract] [Full Text] [Related]
35. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome]. Bessho T, Kanazawa R, Shiotani T, Mitsuo M, Koyama K. Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar 25; 47(3):237-43. PubMed ID: 7535328 [Abstract] [Full Text] [Related]
37. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol. Extermann P, Bischof P, Marguerat P, Mermillod B. Hum Reprod; 1998 Jan 25; 13(1):220-3. PubMed ID: 9512261 [Abstract] [Full Text] [Related]
38. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. BMJ; 1992 Aug 15; 305(6850):391-4. PubMed ID: 1382768 [Abstract] [Full Text] [Related]
40. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome. Werner MJ. Obstet Gynecol; 1995 Jan 15; 85(1):157-8. PubMed ID: 7528369 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]